Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma - PubMed (original) (raw)
Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma
R Gilbertson et al. Genes Chromosomes Cancer. 2001 Jul.
Abstract
We recently reported a significant relationship between tumor cell expression of the ERBB4 receptor, the most recently described member of the epidermal growth factor receptor family, and aggressive tumor phenotype in childhood medulloblastoma. Two alternative juxtamembrane (JM) isoforms of the ERBB4 receptor have been described. Termed JMa and JMb, these variants possess different receptor processing and ligand-binding characteristics. In the current study, we employed an RT-PCR and sequencing strategy to determine the pattern of ERBB4 JM isoform expression in a large (n = 78) series of pediatric medulloblastomas. JMa and JMb transcript expression was detected in 53% and 28% of tumor samples, respectively. In addition, two novel ERBB4 JM isoforms, which we have termed JMc and JMd, were isolated from 10% and 36% of tumors, respectively. Sequence analysis revealed the JMc transcript to contain a deletion of the entire JM region. In contrast, JMd includes an extended coding region, retaining both the JMa and JMb sequences. Neither of these novel isoforms was detected in normal human adult cerebellum, but expression of JMd was observed in developing fetal cerebellum, suggesting that this later isoform may represent an ERBB4 transcript restricted to primitive neuroectoderm-derived tissue. To confirm that the four ERBB4 JM isoforms arise by alternative RNA splicing, we sequenced the intron-exon junctions of the human ERBB4 gene within the JM region. This demonstrated the four ERBB4 JM variants to be encoded by two short exons containing the JMb and JMa sequences positioned in the order 5' to 3' and separated by a 121 bp intron.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
- Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer.
Gilmour LM, Macleod KG, McCaig A, Gullick WJ, Smyth JF, Langdon SP. Gilmour LM, et al. Cancer Res. 2001 Mar 1;61(5):2169-76. Cancer Res. 2001. PMID: 11280782 - Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.
Reiter JL, Threadgill DW, Eley GD, Strunk KE, Danielsen AJ, Sinclair CS, Pearsall RS, Green PJ, Yee D, Lampland AL, Balasubramaniam S, Crossley TD, Magnuson TR, James CD, Maihle NJ. Reiter JL, et al. Genomics. 2001 Jan 1;71(1):1-20. doi: 10.1006/geno.2000.6341. Genomics. 2001. PMID: 11161793 - Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants.
Junttila TT, Sundvall M, Määttä JA, Elenius K. Junttila TT, et al. Trends Cardiovasc Med. 2000 Oct;10(7):304-10. doi: 10.1016/s1050-1738(01)00065-2. Trends Cardiovasc Med. 2000. PMID: 11343971 Review. - Function of ERBB4 is determined by alternative splicing.
Veikkolainen V, Vaparanta K, Halkilahti K, Iljin K, Sundvall M, Elenius K. Veikkolainen V, et al. Cell Cycle. 2011 Aug 15;10(16):2647-57. doi: 10.4161/cc.10.16.17194. Epub 2011 Aug 15. Cell Cycle. 2011. PMID: 21811097 Review.
Cited by
- Emerging treatments and gene expression profiling in high-risk medulloblastoma.
Sardi I, Cavalieri D, Massimino M. Sardi I, et al. Paediatr Drugs. 2007;9(2):81-96. doi: 10.2165/00148581-200709020-00002. Paediatr Drugs. 2007. PMID: 17407364 Review. - ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.
Longo JF, Brosius SN, Black L, Worley SH, Wilson RC, Roth KA, Carroll SL. Longo JF, et al. Cell Commun Signal. 2019 Jul 10;17(1):74. doi: 10.1186/s12964-019-0388-5. Cell Commun Signal. 2019. PMID: 31291965 Free PMC article. - Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.
Huse JT, Holland EC. Huse JT, et al. Nat Rev Cancer. 2010 May;10(5):319-31. doi: 10.1038/nrc2818. Nat Rev Cancer. 2010. PMID: 20414201 Review. - ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics.
Arteaga CL, Engelman JA. Arteaga CL, et al. Cancer Cell. 2014 Mar 17;25(3):282-303. doi: 10.1016/j.ccr.2014.02.025. Cancer Cell. 2014. PMID: 24651011 Free PMC article. Review. - miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.
Liang H, Liu M, Yan X, Zhou Y, Wang W, Wang X, Fu Z, Wang N, Zhang S, Wang Y, Zen K, Zhang CY, Hou D, Li J, Chen X. Liang H, et al. J Biol Chem. 2015 Jan 9;290(2):926-40. doi: 10.1074/jbc.M114.621409. Epub 2014 Nov 12. J Biol Chem. 2015. PMID: 25391651 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials